Skip to main content
Journal cover image

High rate of positive lymph nodes in T1a gallbladder cancer does not translate to decreased survival: a population-based, propensity score adjusted analysis.

Publication ,  Journal Article
Köhn, N; Maubach, J; Warschkow, R; Tsai, C; Nussbaum, DP; Candinas, D; Gloor, B; Schmied, BM; Blazer, DG; Worni, M
Published in: HPB (Oxford)
November 2018

BACKGROUND: Current consensus guidelines suggest that gallbladder cancer (GBC) patients with resected T1a disease can be observed while patients with T1b or greater lesions should undergo lymphadenectomy (LNE). The primary aim of this study was to critically explore the impact of LNE in early-stage GBC on overall survival (OS) on a population-based level. METHOD: The 2004-2014 National Cancer Database was reviewed to identify non-metastatic GBC patients with T1a, T1b, or T2 disease and grouped whether a dedicated LNE was performed. OS and relative survival were assessed using Cox proportional hazard regression analyses before and after propensity score adjustments. RESULTS: 4015 patients were included, 246 (6%) had T1a, 654 (16%) T1b, and 3115 (78%) T2 GBC. The rate of positive lymph nodes was 13%, 12%, and 40% for T1a, T1b, and T2 tumors, respectively. Even after propensity score adjustment, no OS benefit was found if LNE was performed for T1a disease (HR:0.63, 95%CI:0.35-1.13) while OS was improved for T1b (HR:0.65, 95%CI:0.49-0.87) and T2 tumors (HR:0.65, 95%CI:0.57-0.73). CONCLUSION: Despite a higher rate of nodal positivity among patients with T1a disease compared to previous reports, there was no impact on survival and current treatment guidelines appear appropriate for the management of T1a disease.

Duke Scholars

Published In

HPB (Oxford)

DOI

EISSN

1477-2574

Publication Date

November 2018

Volume

20

Issue

11

Start / End Page

1073 / 1081

Location

England

Related Subject Headings

  • United States
  • Treatment Outcome
  • Surgery
  • Risk Factors
  • Risk Assessment
  • Retrospective Studies
  • Propensity Score
  • Predictive Value of Tests
  • Middle Aged
  • Male
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Köhn, N., Maubach, J., Warschkow, R., Tsai, C., Nussbaum, D. P., Candinas, D., … Worni, M. (2018). High rate of positive lymph nodes in T1a gallbladder cancer does not translate to decreased survival: a population-based, propensity score adjusted analysis. HPB (Oxford), 20(11), 1073–1081. https://doi.org/10.1016/j.hpb.2018.05.007
Köhn, Nastassja, Johannes Maubach, Rene Warschkow, Catherine Tsai, Daniel P. Nussbaum, Daniel Candinas, Beat Gloor, Bruno M. Schmied, Dan G. Blazer, and Mathias Worni. “High rate of positive lymph nodes in T1a gallbladder cancer does not translate to decreased survival: a population-based, propensity score adjusted analysis.HPB (Oxford) 20, no. 11 (November 2018): 1073–81. https://doi.org/10.1016/j.hpb.2018.05.007.
Köhn N, Maubach J, Warschkow R, Tsai C, Nussbaum DP, Candinas D, et al. High rate of positive lymph nodes in T1a gallbladder cancer does not translate to decreased survival: a population-based, propensity score adjusted analysis. HPB (Oxford). 2018 Nov;20(11):1073–81.
Köhn, Nastassja, et al. “High rate of positive lymph nodes in T1a gallbladder cancer does not translate to decreased survival: a population-based, propensity score adjusted analysis.HPB (Oxford), vol. 20, no. 11, Nov. 2018, pp. 1073–81. Pubmed, doi:10.1016/j.hpb.2018.05.007.
Köhn N, Maubach J, Warschkow R, Tsai C, Nussbaum DP, Candinas D, Gloor B, Schmied BM, Blazer DG, Worni M. High rate of positive lymph nodes in T1a gallbladder cancer does not translate to decreased survival: a population-based, propensity score adjusted analysis. HPB (Oxford). 2018 Nov;20(11):1073–1081.
Journal cover image

Published In

HPB (Oxford)

DOI

EISSN

1477-2574

Publication Date

November 2018

Volume

20

Issue

11

Start / End Page

1073 / 1081

Location

England

Related Subject Headings

  • United States
  • Treatment Outcome
  • Surgery
  • Risk Factors
  • Risk Assessment
  • Retrospective Studies
  • Propensity Score
  • Predictive Value of Tests
  • Middle Aged
  • Male